CMG
50
2
CVS
47
2
FLR
48
6
OMC
42
7
RF
66
5
CPB
39
-3
AAL
27
4
AZO
58
-2
TRIP
44
4
IVZ
39
6
UNP
39
6
TSN
52
-2
UNH
13
2
VZ
54
2
NVDA
52
2
BWA
53
5
ICE
67
3
CMI
51
2
L
52
2
MAC
47
3
CMG
50
2
CVS
47
2
FLR
48
6
OMC
42
7
RF
66
5
CPB
39
-3
AAL
27
4
AZO
58
-2
TRIP
44
4
IVZ
39
6
UNP
39
6
TSN
52
-2
UNH
13
2
VZ
54
2
NVDA
52
2
BWA
53
5
ICE
67
3
CMI
51
2
L
52
2
MAC
47
3
Financhill
Back

SpringWorks Therapeutics Vs. Charles River Laboratories International Industry Stock Comparison

Buy
57

SWTX
SpringWorks Therapeutics

Last Price:
$44.31
Seasonality Move:
5.38%
Sell
34

CRL
Charles River Laboratories International

Last Price:
$114.33
Seasonality Move:
4.79%
Buy
57
SpringWorks Therapeutics (SWTX) is a Buy

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $44.93. The Score for SWTX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • SWTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Charles River Laboratories International (CRL) is a Sell

Is Charles River Laboratories International a Buy, Sell or Hold?

  • The current Charles River Laboratories International [CRL] share price is $115.76. The Score for CRL is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $44.93
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRL Stock Price Chart

What is Charles River Laboratories International's stock price today?

  • The Charles River Laboratories International share price today is $115.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRL is experiencing buying pressure, which is a positive indicator for future bullish movement.

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.69 Sell
Relative Strength Index (14 RSI): 56.56 Buy
Chaikin Money Flow: 4909709 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.96 - 46.88) Buy
Bollinger Bands (100): (35.71 - 50.27) Buy

CRL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.22 Buy
Relative Strength Index (14 RSI): 40.51 Sell
Chaikin Money Flow: 2512544 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (108.28 - 156.52) Sell
Bollinger Bands (100): (139.82 - 191.02) Sell

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.3 Buy
20-day SMA: 40.24 Buy
50-day SMA: 47.8 Sell
200-day SMA: 39.22 Buy
8-day EMA: 40.31 Buy
20-day EMA: 41.05 Buy
50-day EMA: 43.25 Buy
200-day EMA: 40.86 Buy

CRL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 107.14 Buy
20-day SMA: 124.54 Sell
50-day SMA: 148.71 Sell
200-day SMA: 183.84 Sell
8-day EMA: 110.49 Buy
20-day EMA: 108.94 Buy
50-day EMA: 79.78 Buy
200-day EMA: 28.93 Buy

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $2.02 per share.

Charles River Laboratories International Earnings Growth & CRL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.87 per share, and an increase next year of $0.77 per share.

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Charles River Laboratories International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):